NCNA ($NCNA) Insider Trading & Smart Money Activity

NCNA · Biotechnology · Latest filing Jun 19, 2026

$NCNA has 2 insider trades on file. Insiders filed 2 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

NCNA insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All NCNA insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Elliott Levy Sell (Disposition to issuer) 23.81M sh -15.3%-28.4% Read
Insider Jeffrey BlossChief Medical Officer Sell (Disposition to issuer) 36.54M sh -15.3%-28.4% Read

1W / 1M / 6M = how NCNA moved from the trade or filing date.

Insider trading in NCNA: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Elliott Levy 1 — Jun 19, 2026
Jeffrey Bloss Chief Medical Officer 1 — Jun 19, 2026

Frequently asked questions

What is the latest insider trade in NCNA?

Elliott Levy filed a sell (disposition to issuer) of 23.81M sh on Jun 19, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text